Clinical trial
A Multicentre, Randomized Phase III Study of Thalidomide Maintenance Treatment in Patients With Diffuse Large B-cell Lymphoma
NCT03016000 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Randomized Phase III Study of Thalidomide Maintenance Treatment in Patients With Diffuse Large B-cell Lymphoma
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 26, 2017
- Completion date
- December 31, 2023
- Enrollment
- 226 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.